Literature DB >> 9531038

Activation of the coagulant pathway in cigarette smokers.

G J Miller1, K A Bauer, J A Cooper, R D Rosenberg.   

Abstract

The effects of chronic cigarette smoking on the coagulation system were examined in 2964 men aged 50 to 61 years and clinically free of cardiovascular disease. Factor VII activity (VIIc), factor VII antigen (VIIag), prothrombin fragment 1+2 (F1.2), fibrinopeptide A (FPA) and fibrinogen were measured in all participants, and activated factor VII (VIIa), factor IX activation peptide (IX pep) and factor X activation peptide (X pep) in a large sub-sample. The levels of all indices except FPA differed significantly between non-smokers, ex-smokers and current smokers. After adjustment for other conventional cardiovascular risk factors, mean VIIc was raised slightly by 3% in ex-smokers and current smokers as compared with non-smokers, owing to increases in VIIa and VIIag. Plasma IX pep, X pep, F1.2 and fibrinogen concentration were highest in current smokers, intermediate in ex-smokers and lowest in non-smokers. These findings accord with the increased risk of arterial thrombosis in smokers.

Entities:  

Mesh:

Year:  1998        PMID: 9531038

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  19 in total

1.  Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

Authors:  Antonio Tello-Montoliu; Vanessa Roldán; Vicente E Climent; Francisco Sogorb; Gregory Y H Lip; Francisco Marín
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 2.  The biology behind the atherothrombotic effects of cigarette smoke.

Authors:  Adam Csordas; David Bernhard
Journal:  Nat Rev Cardiol       Date:  2013-02-05       Impact factor: 32.419

3.  Acute renal infarction in a heavy smoker.

Authors:  Ihsan Ergun; Kenan Keven; Basol Canbakan; Yakup Ekmekci; Billur Sezgin; Gokhan Nergizoglu; Kenan Ates; Oktay Karatan
Journal:  Int Urol Nephrol       Date:  2007-03-21       Impact factor: 2.370

4.  Nicotine aggravates the brain postischemic inflammatory response.

Authors:  Shayna T Bradford; Svetlana M Stamatovic; Raj S Dondeti; Richard F Keep; Anuska V Andjelkovic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

5.  Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators.

Authors:  J M Walenga; D Hoppensteadt; R Pifarré; M D Cressman; D B Hunninghake; N L Fox; M L Terrin; J L Probstfield
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

6.  Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).

Authors:  Paula I Burgos; Gerald McGwin; John D Reveille; Luis M Vilá; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2010-05-23       Impact factor: 7.580

7.  Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers.

Authors:  John H Warner; Qiwei Liang; Mohamadi Sarkar; Paul E Mendes; Hans J Roethig
Journal:  BMC Med Res Methodol       Date:  2010-03-16       Impact factor: 4.615

8.  Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier.

Authors:  M Hossain; T Sathe; V Fazio; P Mazzone; Babette Weksler; D Janigro; E Rapp; L Cucullo
Journal:  Brain Res       Date:  2009-06-17       Impact factor: 3.252

9.  Protecting the BBB endothelium against cigarette smoke-induced oxidative stress using popular antioxidants: Are they really beneficial?

Authors:  Mohammad Abul Kaisar; Shikha Prasad; Luca Cucullo
Journal:  Brain Res       Date:  2015-09-26       Impact factor: 3.252

10.  The incidence and risk factors of deep venous thrombosis in lower extremities following surgically treated femoral shaft fracture: a retrospective case-control study.

Authors:  Zhixin Ren; Yufei Yuan; Wei Qi; Yanbao Li; Pengcheng Wang
Journal:  J Orthop Surg Res       Date:  2021-07-09       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.